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A B S T R A C T
Autophagy is an important cell recycling program responsible for the clearance of damaged or long-lived
proteins and organelles. Pharmacological modulators of this pathway have been extensively utilized in a wide
range of basic research and pre-clinical studies. Baﬁlomycin A1 and chloroquine are commonly used
compounds that inhibit autophagy by targeting the lysosomes but through distinct mechanisms. Since it is
now clear that mitochondrial quality control, particularly in neurons, is dependent on autophagy, it is important
to determine whether these compounds modify cellular bioenergetics. To address this, we cultured primary rat
cortical neurons from E18 embryos and used the Seahorse XF96 analyzer and a targeted metabolomics
approach to measure the eﬀects of baﬁlomycin A1 and chloroquine on bioenergetics and metabolism. We found
that both baﬁlomycin and chloroquine could signiﬁcantly increase the autophagosome marker LC3-II and
inhibit key parameters of mitochondrial function, and increase mtDNA damage. Furthermore, we observed
signiﬁcant alterations in TCA cycle intermediates, particularly those downstream of citrate synthase and those
linked to glutaminolysis. Taken together, these data demonstrate a signiﬁcant impact of baﬁlomycin and
chloroquine on cellular bioenergetics and metabolism consistent with decreased mitochondrial quality
associated with inhibition of autophagy.
1. Introduction
The autophagy-lysosomal pathway plays an important role in
protein and organelle homeostasis [1–4]. This pathway involves the
engulfment of proteins or organelles by autophagosomes and subse-
quent degradation by lysosomes. This is a multi-step, dynamic process
involving greater than 32 autophagy related proteins and lysosomal
components [1–6]. Pharmacological inhibitors of autophagy either at
initiation or completion have been used widely in both normal and
pathologic states in a variety of cells and tissues to provide insights into
the protective or deleterious roles of autophagy. Their use has been
indispensable in measuring autophagy and lysosomal activities and in
some instances these inhibitors have been used in the clinic as well [7–
13]. However, whether these compounds have oﬀ target eﬀects on
cellular bioenergetics is not clear. Interestingly, targeting the autop-
hagy-lysosomal pathway would be expected to inhibit mitophagy and
result in decreased mitochondrial quality. This view is supported by
data in mitochondria isolated from ATG7 knockout mouse skeletal
muscle that shows decreased mitochondrial respiration. Furthermore,
MEFs isolated from these mice also show decreased basal and maximal
oxygen consumption rates [14]. In this study we hypothesized that two
structurally diverse and commonly used pharmacological agents, which
both inhibit autophagy at the level of the lysosome through distinct
mechanisms, should exhibit convergent eﬀects on mitochondrial
quality and cellular bioenergetics. This was tested using baﬁlomycin
and chloroquine by assessing their eﬀects on LC3-II accumulation,
bioenergetics, and metabolism in primary neurons.
The macrolide antibiotic baﬁlomycin A1 was among the ﬁrst of this
class isolated from Streptomyces gresius, and has been shown to be a
potent inhibitor of the Vacuolar H+ATPase which controls pH in the
lysosome (V-ATPase) [15–17]. Through this mechanism baﬁlomycin
inhibits autophagic ﬂux by preventing the acidiﬁcation of endosomes
and lysosomes [18,19]. The mechanisms of action of baﬁlomycin are
complex. In one study, it was shown that it does not aﬀect the E. coli
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F1,Fo-ATPase or the N. crassa mitochondrial F1,Fo-ATPase in vitro
over a wide range of concentrations [15]. On the other hand,
baﬁlomycin at low nM concentrations was reported to act as a
potassium ionophore and at 30–100 nM decreases mitochondrial
membrane potential and O2 consumption, and at ~300 nM induces
swelling in isolated mitochondria from rat liver [20]. In diﬀerentiated
PC12 cells, SH-SY5Y cells and cerebellar granule neurons, baﬁlomycin
(at 50–250 nM after 45 min) partially uncouples mitochondria due to a
decrease in the proportion of polarized mitochondria, i.e. stochastic
ﬂickering. Furthermore, it was shown to decrease the mitochondrial
pH, Ca2+ and ΔΨm. This was associated with an elevation of
mitochondrial respiration as assayed by MitoXpress and PtCPTE-
CFR9 ﬂuorescent probes both dose and time dependently [21]. These
data suggest that baﬁlomycin has a number of oﬀ-target eﬀects on
mitochondria directly, making it diﬃcult to determine which are a
consequence of inhibiting autophagy. This is potentially important as
the translational capability of baﬁlomycin is being explored in a wide
range of models. For example, there is evidence that baﬁlomycin
inhibits viral replication of Inﬂuenza A and B in canine kidney cells
[22,23]. In cancer, baﬁlomycin alone or as a co-treatment appears to be
eﬀective in enhancing the eﬃcacy of other therapies [24–26]. Given the
complex interactions between metabolism and autophagy we reasoned
additional insight could be gained by comparing the impact of
baﬁlomycin on cellular bioenergetics. This is an integrated measure
of mitochondrial metabolism, with the cell providing its own substrates
compared to measurements of individual components of the respira-
tory chain under conditions where substrates are not limiting. This can
then be compared with parameters of mitochondrial quality to
determine mechanism.
Similar to baﬁlomycin, the former malaria drug chloroquine (CQ) is
now widely used as an inhibitor of autophagy in both cell culture and in
vivo [13]. Chloroquine has a long history of human use and is currently
being tested as a sensitizing agent for certain cancers, making under-
standing its mechanisms of action both topical and important [7–9].
Chloroquine is a lysosomotropic weak base, which in the monoproto-
nated form diﬀuses into the lysosome, where it becomes diprotonated
and becomes trapped. Protonated chloroquine then changes the
lysosomal pH, thereby inhibiting autophagic degradation in the lyso-
somes [27]. And while the direct eﬀects of chloroquine on mitochon-
dria have not been, to our knowledge, extensively studied, there is
evidence to suggest that in already compromised mitochondria, as is
the case in cardiac pressure overload, chloroquine exacerbates the
decrease in mitochondrial quality and function [28].
Autophagy plays a critical role in maintaining healthy mitochon-
drial populations through mitochondrial speciﬁc recycling termed
mitophagy. Mitochondria are key components in the cell responsible
for not only energy production but for varied and diverse signaling
pathways [29,30]. Failure to maintain a population of healthy mito-
chondria can lead to decreased energy production, increased reactive
oxygen species production and eventually to cytotoxicity. These out-
comes are especially evident in chronic diseases including neurode-
generative and heart diseases [1,2,5,30–32]. Since pharmacological
inhibitors of autophagy are frequently used and combined with
measurements of mitochondrial function, it is important to determine
their eﬀects in a deﬁned cellular system. In addition to oxidative
phosphorylation, mitochondria metabolism is also essential for multi-
ple cellular functions beyond energetics [33–35].
In the present study, we have used primary cortical rat neurons to
evaluate how the autophagy inhibitors chloroquine and baﬁlomycin
aﬀect mitochondrial bioenergetics and metabolism. We used the
Seahorse extracellular ﬂux analyzer and a targeted metabolomics
approach to determine parameters of mitochondrial bioenergetics
and metabolism in intact neurons providing a cellular context for
understanding the autophagy pathway and its inhibitors. We have
found that both chloroquine and baﬁlomycin decrease mitochondrial
quality to a similar extent when levels are titrated to achieve a
comparable level of autophagy inhibition.
2. Methods
2.1. Chemicals
Baﬁlomycin A1 (B1793), chloroquine (C6628), oligomycin (75351),
FCCP (C2920), rotenone (R8875), antimycin-A (A8674), pyruvate
(P5280), malate (M6413), ADP (A2754), succinate (S2378) were all
obtained from Sigma. Neurobasal medium (21103-049), B-27 supple-
ment (17504044-044), L-glutamine (25030-081) and penicillin-strep-
tomycin (15140-122) were obtained from Life Technologies. PMP
(102504) was obtained from Seahorse Bioscience.
2.2. Cell Culture
Primary cortical rat neurons were isolated at embryonic day E18.
Dissections were performed in HBSS media and plated on poly-L-
Lysine coated plates using Neural Basal media supplemented with L-
glutamine, B27, and Penicillin/Streptomycin. Experiments were per-
formed on DIV7, when half of the media was replaced with each
compound diluted in Neural Basal supplemented with L-glutamine and
Penicillin/Streptomycin only.
2.3. Cell viability
Cells were plated at 80k on XF96 plates and exposed for 24 h to
baﬁlomycin or chloroquine. Cell viability was measured 24 h after the
exposure by the Trypan Blue exclusion method.
2.4. Western blot analysis
Neurons were plated on 24-well plates seeded at 480k cells per well.
After exposures to the pharmacological compounds, medium was
aspirated. Cells were then washed once with ice cold PBS, and 40 µL
of RIPA lysis buﬀer (50 mM Tris pH 7.8, 150 mM NaCl, 2 mM EDTA,
1% Triton X-100%, and 0.1% SDS) with 1x Roche protease inhibitors
(4693132001) was added to each well and cells were scraped. Two
wells were then combined and centrifuged at 16,800×g for 15 min at
4 °C. The supernatant was collected and protein was measured using
the BCA protein assay. 5x loading buﬀer was added to samples and
then separated by SDS-PAGE using 12% or 15% polyacrylamide gels.
Membranes were then immunoblotted for LC3 (Sigma L8918 1:2000),
Citrate synthase (AB96600 1:1000), PGC1-α (SC-13067 1:1000), p62
(Abnova H00008878-M01 1:2000), aconitase (aﬃnity puriﬁed as
previously described [36], was a generous gift from Scott Ballinger at
UAB) and actin (Sigma A5441 1:2500). Subunits of mitochondrial
oxidative phosphorylation complexes I-V were blotted for by using
Abcam's total OXPHOS rodent antibody cocktail (AB110413). Images
were collected using an Amersham™ Imager600. Images were then
analyzed using ImageJ [37].
2.5. Mitochondrial DNA copy number and DNA damage assays
Cells were plated at 480k cells per well on 24 well plates and were
treated for 24 h. After treatment, DNA was extracted. Quantitative real-
time PCR was performed using SYBR green in an ABI 7500 machine.
Mitochondrial DNA copy number was determined by normalizing
results from primers targeted to mtDNA (Forward: 5'-
CCAAGGAATTCCCCTACACA-3' and Reverse: 5′-GAAATT
GCGAGAATGGTGGT-3′) against results from primers targeted to
nuclear 18S DNA (Forward: 5'-CGAAAGCATTTGCCAAGAAT-3' and
Reverse: [38,39]. Mitochondrial DNA damage was determined by PCR
as previously described [40]. Brieﬂy, mtDNA long segments
(Forward: 5′-GGACAAATATCATTCTGAGGAGCT-3′ Reverse: (5′-
GGATTAGTCAGCCGTAGTTTACGT-3′) and short segments
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(Forward: 5′-CCAAGGAATTCCCCTACACA-3′ Reverse: 5′-
GAAATTGCGAGAATGGTGGT-3′) were ampliﬁed using an
AccuPrimeTM Taq DNA Polymerase High Fidelity kit (Life Tech
Corp). The products were separated on agarose gels, visualized by
ethidium bromide, and analyzed by ImageJ. mtDNA Long PCR
conditions were: 94 °C for 11 s, 25 cycles of denaturation at 94 °C for
15 s, annealing and extension at 67 °C for 12 min, and ﬁnal extension
at 72 °C for 10 min mtDNA Short PCR conditions were: 94 °C for 6 s,
18 cycles of denaturation at 94 °C for 20 s, annealing and extension at
65 °C for 1 min, and ﬁnal extension at 72 °C for 10 min. Lesion
frequency was calculated as follows [41]:
⎡
⎣⎢
⎤
⎦⎥
Lesion frequency per 16kb of each sample
=− Ln long PCR product / short PCR product
mean of (long PCR product / short PCR product) from control group
2.6. Bioenergetic analysis
Bioenergetic proﬁles were determined using the Seahorse
Bioscience Extracellular Flux Analyzer (XF96) [42]. Cells were isolated
as above and plated at 80k cells per well on XF96 plates. For
mitochondrial stress test in intact neurons, after exposure to autophagy
inhibitors, cells were switched to XF media 30 min prior to measure-
ment of oxygen consumption rate (OCR), followed by sequential
injection of oligomycin (1 µg/mL), FCCP (1 µM), and rotenone
(1 µM)+antimycin A (10 µM), with 2 OCR measurements after each
injection [42]. Total protein per well was measured by Lowry DC
protein assay and OCR normalized to protein. Basal OCR was
calculated as OCR before oligomycin minus OCR after Antimycin.
Maximal OCR was calculated as OCR after FCCP minus OCR after
Antimycin. Reserve Capacity was calculated as OCR after FCCP minus
OCR before oligomycin. ATP-linked OCR was calculated as OCR before
oligomycin minus OCR after oligomycin. Proton leak OCR was
calculated as OCR after oligomycin minus OCR after Antimycin.
Non-mitochondrial OCR is the OCR after antimycin injection.
For mitochondrial activity assay in permeabilized cells, 5 min prior
to assay, cells were switched to MAS buﬀer (70 mM sucrose, 220 mM
mannitol, 10 mM KH2PO4, 5 mM MgCl2, 2 mM HEPES, 1 mM EGTA,
adjusted pH to 7.2) [43]. OCR was measured after injection 1 nM PMP
(Seahorse Plasma Membrane Permeabilizer) plus complex I modula-
tors (10 mM pyruvate, 1 mMmalate and 1 mM ADP or 1 µM FCCP) for
complex I activity assays, then injected with 1 μM rotenone to inhibit
complex I activity, followed by injection of complex II modulators
(10 mM succinate) to assay for complex II activity, then injected with
10 µM Antimycin. Complex IV activity was measured in PMP permea-
bilized neurons in MAS buﬀer by injection of PMP (1 nM) plus TMPD
0.5 mM, ascorbate 2 mM, and 1 mM ADP; after 2 measurements the
inhibitor azide 20 mM was injected. Complex I activity was calculated
as the diﬀerence between before and after rotenone injection. Complex
II activity was calculated as the diﬀerence between before and after
antimycin injection. Complex IV activity was calculated as the diﬀer-
ence after ascorbate injection and after azide injection. The experi-
ments were repeated with > 3 independent cultures. Because of
signiﬁcant protein loss during assays utilizing MAS buﬀer, accurate
measure of total protein was unobtainable, thus raw data is repre-
sented.
2.7. Metabolomics
Cells were plated on 24 well plates at 480k per well and treated with
autophagy modulators for 24 h. Upon completion of treatment the cells
were washed with 1 mL of ice cold PBS. The cells were then lysed and
scraped in 500 µL of HPLC grade ice cold methanol and incubated at
−80 °C for 2 h. Plates were scraped again and cell lysates were
transferred to glass tubes where they were centrifuged at ~1000×g
for 20 min at 4 °C. Supernatants were transferred to new glass tubes
and stored at −80 °C until further processing [44].
Standards were generated as a master mix of all compounds at
100 μg/mL in H2O and serial diluted to 10x of the ﬁnal concentrations
(0.05–10 μg/mL, 9 standards). Standards were further diluted to 1x in
methanol to a total volume of 1 mL, and dried by a gentle stream of N2.
For cell extracts, 1 mL of each were transferred to a glass tube and
dried under a gentle stream of N2. Standards and samples were
resuspended in 50 µL of 5% acetic acid and vortexed for 15 s.
Amplifex™ Keto Reagent (SCIEX, Concord, Ontario, Canada) (50 µL)
was added to each sample and allowed to react for 1 h at room
temperature. Standards and samples were then dried under a gentle
stream of N2 and resuspended in 1 mL and 200 µL of 0.1% formic acid,
respectively.
Samples were analyzed by LC-multiple reaction ion monitoring-
mass spectrometry. Liquid chromatography was performed by LC20AC
HPLC system (Shimadzu, Columbia, MD) with a Synergi Hydro-RP
4 µm 80 A 250×2 mm ID column (Phenomenex, Torrance, CA). Mobile
phases were: A) 0.1% formic acid and B) methanol/0.1% formic acid.
Compounds were eluted using a 5–40% linear gradient of B from 1 to
7 min, followed by a column wash of 40–100% B from 7 to 10 min, and
re-equilibrated at 5% B from 10.5 to 15 min. Column eluant was passed
into an electrospray ionization interface of an API 4000 triple-quadru-
pole mass spectrometer (SCIEX). The following mass transitions were
monitored in the positive ion mode: m/z 261/118 for α-ketoglutarate,
m/z 247/144 for oxaloacetate and m/z 204/144, 204/118 and 204/60
for pyruvate. In the negative mode, the following transitions are
monitored: m/z 115/71 for fumarate, m/z 89/43 for lactate, m/z
117/73 for succinate, m/z 133/115 for malate, m/z 173/85 for cis-
aconitate, m/z 191/87 for citrate, m/z 191/73 for isocitrate, m/z 147/
129 for 2-hydroxyglutarate, m/z 146/102 for glutamate, m/z 145/42
for glutamine and m/z 132/88 for aspartate. The 16 transitions were
each monitored for 35 ms, with a total cycle time of 560 ms. MS
parameters were CAD 4, CUR 15, GS1 60, GS2 30, TEM 600, IS
−3500 V for negative polarity mode and IS 4500 for positive polarity
mode. Peak areas of metabolites in the sample extracts are compared in
MultiQuant software (SCIEX) to those of the known standards to
calculate metabolite concentrations.
2.8. Citrate activity assay
Neurons were plated at 480k/well on 24 well plates. Cells were
scraped into RIPA lysis buﬀer as before and frozen until assayed.
Activity was measured using a Beckman Coulter DU800 spectro-
photometer. 945 µL of 100 mM Tris (pH 8.0 at 37 °C) with 0.1%
Triton X-100 was added to cuvette followed by 25 µL of sample, 10 µL
of 10 mM acetyl-CoA, 10 µL 5,5′-dithiobis(2,4-nitrobenzoic acid), and
10 µL 20 mM oxaloacetate. Activity was measured for 4 min. The rate
was calculated from the linear range and was normalized to total
protein.
2.9. Normalized activity calculations
Citrate synthase activity (nmol/min/mg protein) was expressed as
the ratio of enzyme activity to relative levels of citrate synthase protein
as determined by western blotting. Complex I, II and IV-linked OCR
were expressed as the ratio of their respective OCR normalized to
relative levels of speciﬁc subunits within each complex as determined
using western blotting.
2.10. Statistics
All results were expressed as mean ± SEM. Statistical analysis of
data were performed by using one-way ANOVA followed by Tukey's
post hoc test. Values of p < 0.05 were considered statistically signiﬁ-
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cant.
3. Results
3.1. Eﬀects of autophagy inhibitors on LC3-II accumulation and
viability
During the autophagy process, LC3-I is converted to LC3-II by
lipidation, resulting in LC3-II migrating diﬀerently on SDS/PAGE.
LC3-II is used as a quantitative marker of autophagy since it is required
for the formation of the autophagosome and its level is proportional to
the amount of autophagosomes in the cell [13,45,46]. To determine
concentrations of baﬁlomycin and chloroquine which result in an
approximately equivalent level of autophagy inhibition, cultured pri-
mary cortical rat neurons at 7 d in vitro (DIV7) were exposed to a range
of concentrations for both compounds for 24 h. Signiﬁcant increases in
LC3-II were observed at 10 and 100 nM but not at 1 nM baﬁlomycin
exposure (Fig. 1A, B). Signiﬁcant increases in LC3-II were observed at
10, 20, and 40 µM concentrations of CQ (Fig. 1C, D). No signiﬁcant
changes in LC3-I were observed. There were no signiﬁcant changes in
the cell viability after exposure to chloroquine for 24 h. However,
exposure to 100 nM but not 10 nM baﬁlomycin, decreased cell viability
by approximately 35% (Fig. 1E). In a direct comparison of these two
autophagy modulators, we observed no signiﬁcant changes in LC3-I,
but statistically similar increases in LC3-II for both baﬁlomycin and
chloroquine exposures. The LC3-II/I ratio reﬂects the conversion of the
protein from the cytosolic form to the autophagosome associated form
upon autophagy activation and was also calculated and showed
signiﬁcant increases for both baﬁlomycin and chloroquine treatments,
although chloroquine was statistically further increased, albeit mod-
estly, from baﬁlomycin. The autophagy substrate p62 was also mea-
sured and showed increased levels for baﬁlomycin (Fig. 1F-J). Given
the toxicity of 100 nM baﬁlomycin and the similar accumulation of
LC3-II with 10 nM baﬁlomycin and 40 µM chloroquine treatments, all
subsequent 24 h time point experiments were performed with these
concentrations.
3.2. Eﬀects of baﬁlomycin and chloroquine on cellular bioenergetics
in intact neurons
Primary cortical rat neurons were exposed to autophagy modulators
for 24 h as before and medium was replaced by XF media free of
Fig. 1. : Eﬀects of baﬁlomycin and chloroquine on autophagy and cell survival. Primary rat cortical neurons at DIV7 were used for experiments. (A-D) Western blot analyses
of LC3-I and LC3-II in lysates in neurons exposed to increasing concentrations of baﬁlomycin (baf) or chloroquine (CQ) for 24 h. (E) Trypan blue exclusion assay of cell viability after
24 h exposure to baf or CQ at indicated concentrations. (F-J) Western blot analyses of p62, LC3-I and LC3-II in lysates in neurons exposed to 10 nM baf and 40 µM CQ. *p < 0.05
compared to control, #p < 0.05 between baf and CQ, Data=mean ± SEM, 3 independent experiments, and each experiment contain 3 independent samples.
M. Redmann et al. Redox Biology 11 (2017) 73–81
76
autophagy modulators, followed by a mitochondrial stress test in intact
cells using XF media. These cells exhibited the typical proﬁle for the
mitochondrial stress test we have previously reported for primary
neurons [38,47]. As expected, after establishing a stable baseline
measurement of oxygen consumption rate (OCR) the injection of
oligomycin resulted in a decrease in OCR due to the inhibition of
ATP synthase. Next, FCCP, a mitochondrial uncoupler was found to
stimulate OCR by depleting the proton gradient. Finally, antimycin was
injected to inhibit consumption of oxygen by the mitochondrial
electron transport chain [32,42]. Basal, ATP-linked, maximal, reserve
capacity, proton leak, and non-mitochondrial OCR were determined
from this trace (Fig. 2A). Both baﬁlomycin exposure at 10 nM and
chloroquine exposure at 40 µM resulted in similar decreases in overall
OCR for basal, ATP-linked, maximal, reserve capacity and non-
mitochondrial related parameters of oxygen consumption. No signiﬁ-
cant changes in proton leak were noted (Fig. 2B-G). Extracellular
acidiﬁcation rate (ECAR), a measurement of proton production from
glycolysis and the TCA cycle, was also recorded using the same
injection protocol as above. Statistically signiﬁcant decreases in
ECAR were observed for both baﬁlomycin and chloroquine and in
the plot of OCR vs ECAR the cells a show a similar and a less energetic
status (Supplemental Figure 1A-C).
Since baﬁlomycin has been reported to inhibit the mitochondrial
ATP synthase and chloroquine can modulate organellar pH, either
compound could acutely inhibit mitochondrial function. To test this,
we measured basal OCR for 4 consecutive readings and then directly
injected the compounds, recorded 4 more basal readings and then
proceeded with a mitochondrial stress test. No discernable decreases of
OCR were observed during the 30 min immediately after direct
injection of the compounds or during the stress test (Supplemental
Figure 2A). No signiﬁcant alterations in p62, LC3-I, or LC3-II protein
levels nor any changes in viability were observed (Supplemental Figure
2B-F).
Fig. 2. Eﬀects of baﬁlomycin and chloroquine on parameters of bioenergetics in intact neurons. (A) Oxygen consumption rate (OCR) from primary cortical neurons
exposed to baﬁlomycin (10 nM) and chloroquine (40 µM) for 24 h was determined by the mitochondrial stress test. OCR was measured before and after sequential injection of
Oligomycin (O, 1 µg/mL), FCCP (F, 1 µM), and Antimycin A (A, 10 µM). (B-G) Basal, maximal, reserve capacity, ATP linked, proton leak, and non-mitochondrial OCR were calculated
from (A) as described in the Methods. *p < 0.05 compared to control, from 3 independent experiments. Shown is the representative experiment with, n≥3 independent samples,
Data=mean ± SEM, n.s.: not signiﬁcant.
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3.3. Eﬀects of baﬁlomycin and chloroquine on mitochondrial complex
I, II and IV substrate–linked respiration
To assess the eﬀect of the autophagy inhibitors on mitochondrial
complexes, cells were exposed to 10 nM baﬁlomycin or 40 µM chlor-
oquine (24 h) under the conditions described in Fig. 2 and then
switched to MAS buﬀer before permeabilization with PMP and OCR
measurements with complex I, II or IV-linked substrates. Complex I
linked respiration was diminished by approximately 65% and 55% for
baﬁlomycin and chloroquine treatment in the presence of ADP,
respectively. In the presence of FCCP, decreases in OCR between
70% and 80% were observed after autophagy inhibitor treatment
(Fig. 3A). Complex II linked activities were diminished by 50% in the
presence of ADP and by 60% in the presence of FCCP after either
baﬁlomycin or chloroquine exposure (Fig. 3B). Complex IV substrate-
linked OCR in the presence of ADP was decreased by ~47% with
baﬁlomycin and by ~30% with chloroquine (Fig. 3C).
3.4. Eﬀects autophagy inhibitors on levels of mitochondrial proteins
and DNA
Given the signiﬁcant decrease in all mitochondrial respiratory
complexes after 24 h exposure we reasoned this could be due to either
a decrease in mitochondrial quality or mitochondrial number. This was
tested using a number of approaches. First, we determined if levels of
selected mitochondrial electron transport chain complexes and Krebs
cycle enzymes were altered by autophagy inhibitors after a 24 h
exposure (Fig. 4A). No signiﬁcant changes in representative subunits
of mitochondrial complexes I-V were observed (Fig. 4B-F). Using these
data and the respiratory chain complex activities (Fig. 3), a normalized
activity was calculated for each complex. Supplemental ﬁgure 3 shows
the complex I, II and IV activities normalized to protein and demon-
strates that they are suppressed by baﬁlomycin or chloroquine by ~40–
80% for all the respiratory chain complexes. It does not appear
mitochondrial biogenesis is activated since we did not observe any
changes on PGC-1α, (Fig. 4G). The levels of Krebs cycle enzyme
aconitase did not change, while citrate synthase showed a modest
increase in protein levels (Fig. 4H, I). Importantly, no signiﬁcant
changes in mtDNA copy number were observed; however, a signiﬁcant
increase in the amount of mitochondrial DNA damage occurred after
baﬁlomycin or chloroquine exposure for 24 h, consistent with a
decrease in mitochondrial quality (Fig. 4J, K).
3.5. Eﬀects autophagy inhibitors on Krebs cycle intermediates
We next determined the level of Krebs cycle metabolites and lactate
using a targeted metabolomics approach (Fig. 5). We detected no
signiﬁcant changes in lactate levels but observed a trend towards
decreased pyruvate levels after baﬁlomycin and chloroquine exposure.
The pyruvate to lactate ratio was then calculated and signiﬁcant
decreases of similar levels were observed after both baﬁlomycin and
chloroquine exposure (Fig. 5A-C). Citrate, cis-aconitate and isocitrate
levels were also measured, with signiﬁcant decreases of both citrate and
isocitrate in response to both baﬁlomycin and chloroquine.
Interestingly, cis-aconitate was decreased by baﬁlomycin but increased
by chloroquine (Fig. 5D-F). Key components of glutaminolysis, in-
cluding α-ketoglutarate, glutamate, and glutamine, were signiﬁcantly
decreased by both baﬁlomycin and chloroquine while succinate levels
remained unchanged (Fig. 5G-J). Fumarate and malate were also
decreased but achieved signiﬁcance with chloroquine only (Fig. 5K, L).
To determine the potential mechanism behind the decrease of Krebs
cycle intermediates in response to baﬁlomycin or chloroquine, we
measured citrate synthase activities and found that it signiﬁcantly
decreased by ~20% after either baﬁlomycin or chloroquine exposure
(Fig. 5M). Furthermore, we normalized its activity to levels of citrate
synthase protein present in the cells, and found an even further
decrease of ~40%, consistent with a substantially lower level of active
protein (Fig. 5N).
4. Discussion
Autophagy gene Atg7 knockout in skeletal muscle, mouse embryo-
nic ﬁbroblasts and pancreatic β cells has been previously found to
exhibit decreased state IV, State III, or basal, ATP-linked, and maximal
activities. Atg7 knockout mouse embryonic ﬁbroblasts also exhibited
increased DCFDA ﬂuorescence suggesting increased production of
reactive oxygen species, and Atg7 knockout pancreatic β cells exhibited
accumulation of swollen dysmorphic mitochondria [14]. This suggests
that autophagy failure leads to a decrease in mitochondrial quality. In
this study we have provided the ﬁrst direct comparison on the eﬀects of
two widely used autophagy inhibitors, baﬁlomycin and chloroquine, on
bioenergetics.
Attenuated autophagy has been reported to accompany cellular
bioenergetic dysfunction in various genetic and oxidative stress models
[48–51]. Previous studies suggested that baﬁlomycin has a direct eﬀect
on mitochondrial function [20,21]. In our study, neither baﬁlomycin
nor chloroquine for 32 min changed OCR in intact cells (Supplemental
Figure 2A). These data indicate that the observed deﬁcits in mitochon-
dria function are not due to oﬀ target eﬀects of the compounds on
mitochondria but rather through autophagy failure resulting in accu-
mulation of damaged mitochondria. Our studies demonstrate that in
neurons, a 24 h exposure to autophagy inhibitors also inhibits para-
Fig. 3. Eﬀects of baﬁlomycin and chloroquine on complexes I, II and IV
substrate-linked OCR in permeabilized neurons. Neurons were exposed to 10 nM
baﬁlomycin (baf) or 40 µM chloroquine (CQ) for 24 h. (A) The activities of complex I
were determined in neurons permeabilized with PMP in the presence of complex I
substrates (pyruvate and malate) utilizing either ADP or FCCP. (B) Complex II linked
activities were determined in similar fashion utilizing complex II substrate succinate in
the presence of either ADP or FCCP. (C) Complex IV linked activities were again
measured using ascorbate and TMPD as substrates with ADP in permeabilized cells. *p <
0.05 compared to control, from 3 independent experiments. Shown is the representative
experiment with n≥3 independent samples, Data=mean ± SEM.
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meters of mitochondrial function (Fig. 2), even in the absence of p62
accumulation, as the case in chloroquine exposure. Furthermore,
decreases were observed for complex I, II, and IV substrate-linked
respiration in permeabilized cells, indicating widespread deﬁciencies in
mitochondrial electron transport chain function (Fig. 3). These deﬁ-
ciencies occurred without any changes in PGC-1α, mitochondrial
electron transport chain proteins, or matrix proteins except for an
increase in citrate synthase and a trend toward increased aconitase
protein which did not reach signiﬁcance (Fig. 4A-I). However, while
citrate synthase protein levels were modestly increased, its activity was
diminished and its normalized activity, was diminished even further
(Fig. 4M, N). Mitochondrial DNA damage was also increased (Fig. 4J,
K). Taken together, these observations are all consistent with a
decrease in mitochondrial quality.
Cellular metabolic programs play important roles in health and
disease [44,52–54]. How metabolic pathways respond to autophagy
inhibition have not been fully investigated. In the metabolomics
analysis we observed that pyruvate or lactate levels themselves showed
no signiﬁcant change, the more sensitive measure of the relative
activity of glycolysis to mitochondrial function, the pyruvate/lactate
ratio, was decreased after baﬁlomycin or chloroquine exposure, con-
sistent with a relative increase in glycolysis (Fig. 5A-C and
Supplemental ﬁgure 1). Furthermore, Krebs cycle intermediates,
including citrate, cis-aconitate, and isocitrate are diminished. This is
likely resulting from the inhibition of citrate synthase and its inability
to provide substrates for downstream processing which was conﬁrmed
by direct measurement of citrate synthase activity (Fig. 5D-F). The
diﬀerences in cis-aconitate levels in response to baﬁlomycin and
chloroquine also suggest a possible decrease in aconitase activity.
Additionally, key components of glutaminolysis, α-ketoglutarate, glu-
tamate, and glutamine, were decreased while succinate, fumarate and
malate have approximately been restored (Fig. 5G-L). This observation
Fig. 4. Increased mitochondrial DNA damage without signiﬁcant changes of PGC-1α, key electron transport chain proteins or mitochondrial DNA copy number in response to
baﬁlomycin or chloroquine. (A) Western blot analysis of subunits of complex I-V, PGC-1α, aconitase, and citrate synthase, in lysates from cells exposed to 10 nM baﬁlomycin or 40 µM
chloroquine for 24 h. (B-I) Relative quantiﬁcation of western blots (A). (J) Analysis of mitochondrial DNA copy number normalized to nuclear DNA. (K) Analysis of mitochondrial DNA
damage. *p < 0.05 compared to control, n≥3 independent samples and treatment from 1 experiment, Data=mean ± SEM.
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would be consistent with an increase in glutaminolysis in an attempt to
restore downstream intermediates.
In summary, at a concentration and duration of exposure that led to
a similar level of accumulation of LC3-II, we found that both
baﬁlomycin and chloroquine also decreased parameters of mitochon-
drial function in intact neurons. The levels of representative mitochon-
drial electron transport chain and mitochondrial matrix proteins were
essentially unchanged by baﬁlomycin or chloroquine, but all showed a
decrease in normalized activity suggesting multiple deﬁcits in mito-
chondrial enzymes in oxidative phosphorylation and the TCA cycle.
Furthermore, mtDNA levels were unchanged but damage was in-
creased. These ﬁndings are consistent with a secondary eﬀect on
bioenergetics by baﬁlomycin and chloroquine due to autophagy
inhibition and a resulting decrease in mitochondrial quality.
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